SHAREHOLDER ALERT: The M&A Class Action Firm Continues to Investigate the Merger—ACA, APGE, BOLD, and GBCS
SHAREHOLDER ALERT: The M&A Class Action Firm Continues to Investigate the Merger--ACA, APGE, BOLD, and GBCS
PR Newswire
NEW YORK, July 2, 2026
NEW YORK, July 2, 2026 /PRNewswire/ -- Class Action Attorney Juan Monteverde with Monteverde & Associates PC (the "M&A Class Action Firm"), has recovered millions of dollars for shareholders and is recognized as a Top 50 Firm in the 2025 ISS Securities Class Action Services Report. We are headquartered at the Empire State Building in New York City and are investigating
- Arcosa, Inc. (NYSE: ACA) related to its sale to CRH Americas, Inc. Under the terms of the proposed transaction, Arcosa shareholders are expected to receive $150.00 per share in cash.
Click here for more info https://monteverdelaw.com/case/arcosa-inc/. It is free and there is no cost or obligation to you.
- Apogee Therapeutics, Inc. (NASDAQ: APGE) related to its sale to AbbVie Inc. Under the terms of the proposed transaction, Apogee shareholders are expected to receive $135.11 per share in cash.
Click here for more information https://monteverdelaw.com/case/apogee-therapeutics-inc/. It is free and there is no cost or obligation to you.
- Boundless Bio, Inc. (NASDAQ: BOLD) related to its merger with Serapha Bio, Inc. Upon closing of the proposed transaction, Boundless Bio shareholders are expected to own approximately 3.7% of the combined company.
Click here for more information https://monteverdelaw.com/case/boundless-bio-inc/. It is free and there is no cost or obligation to you.
- Selectis Health, Inc. (OTCMKTS: GBCS) related to its sale to Black Pearl Equities II, LLC. Under the terms of the proposed transaction, Selectis Health shareholders will receive $5.75 per share in cash.
Click here for more info https://monteverdelaw.com/case/selectis-health-inc/. It is free and there is no cost or obligation to you.
NOT ALL LAW FIRMS ARE THE SAME. Before you hire a law firm, you should talk to a lawyer and ask:
- Do you file class actions and go to Court?
- When was the last time you recovered money for shareholders?
- What cases did you recover money in and how much?
About Monteverde & Associates PC
Our firm litigates and has recovered money for shareholders…and we do it from our offices in the Empire State Building. We are a national class action securities firm with a successful track record in trial and appellate courts, including the U.S. Supreme Court.
No company, director or officer is above the law. If you own common stock in the above listed company and have concerns or wish to obtain additional information free of charge, please visit our website or contact Juan Monteverde, Esq. either via e-mail at jmonteverde@monteverdelaw.com or by telephone at (212) 971-1341.
Contact:
Juan Monteverde, Esq.
MONTEVERDE & ASSOCIATES PC
The Empire State Building
350 Fifth Ave. Suite 4740
New York, NY 10118
United States of America
jmonteverde@monteverdelaw.com
Tel: (212) 971-1341
Attorney Advertising. (C) 2026 Monteverde & Associates PC. The law firm responsible for this advertisement is Monteverde & Associates PC (www.monteverdelaw.com). Prior results do not guarantee a similar outcome with respect to any future matter.
SOURCE Monteverde & Associates PC
The articles, information, and content displayed on this webpage may include materials prepared and provided by third parties. Such third-party content is offered for informational purposes only and is not endorsed, reviewed, or verified by Morningstar.
Morningstar makes no representations or warranties regarding the accuracy, completeness, timeliness, or reliability of any third-party content displayed on this site. The views and opinions expressed in third-party content are those of the respective authors and do not necessarily reflect the views of Morningstar, its affiliates, or employees.
Morningstar is not responsible for any errors, omissions, or delays in this content, nor for any actions taken in reliance thereon. Users are advised to exercise their own judgment and seek independent financial advice before making any decisions based on such content. The third-party providers of this content are not affiliated with Morningstar, and their inclusion on this site does not imply any form of partnership, agency, or endorsement.
Popular
Your 7-Figure Retirement Fund Might Not Stretch As Far As You Think. Here’s How to Change That
This Wide-Moat Stock Is Still a Buy After Its Rally
These 15 Stocks Destroyed the Most Shareholder Value Over the Past Decade
What Doubters Get Wrong About the 60/40 Portfolio
United States